ISPOR Europe 2026
Panel Access and Pricing track
Delay or Prepare? Navigating EU HTA in the Era of MFN-Driven Launch Uncertainty
Tue, Nov 10, 2026 · 1:45–2:45 PM CET Hall E1, Level 0, Austria Center Vienna
About this session
ISSUE Global pricing pressures, including Most Favored Nation (MFN) and intensified reference pricing (ERP), are reshaping pharmaceutical launch strategies. Companies are delaying or deprioritizing European launches to protect global pricing corridors.
Speakers
-
Passage Health Associates
Moderator
-
Panelist
